News

Medical Dialogues11h
EMA flags rare vision risk with Semaglutide- a active substance in Ozempic, Rybelsus, Wegovy
European Medicines Agency (EMA)'s safety committee (PRAC) has concluded its review of medicines containing semaglutide ...
Best Life on MSN13h
Ozempic Users Face 2x Higher Risk of Permanent Vision Loss, Researchers Warn
Ozempic and other GLP-1 drugs have forever altered the way people view, manage, and speak about obesity. However, it’s ...
Novo's Ozempic linked to rare cases of serious eye disorder, EU regulator says
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
Samaa TV17h
Ozempic linked to rare cases of serious eye disorder
The European Medicines Agency warns that Novo Nordisk's Ozempic and Wegovy may, in rare cases, cause NAION—a serious eye condition that can lead to vision loss. The EMA has asked the company to update ...